NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.
The Longterm Downtrend appears to be closing, bottomed in May, double bottom is in and a Golden Cross is very close on the daily chart. Shallow Uptrend is in play, we should hopefully see some strong action coming into May 2021.
Hopefully those holding longterm should get some relief. Swing Traders may want to "LOCK AND...
*The company have a gap to $4.70.
*Advantage of he company now is : Stock price is above the SMA 200. (If the price have a spike now , it have more chance of gap up to $4.70
*Is a slow moving stock but very volatil.
* I think the company only will need the Nasdaq Comply of staying above $1.
This is only my Idea, don't buy or sell because of my...
AMEX:NBY Trading in a channel, sitting on bottom, looking for a bounce off bottom channel this week towards midline. tight stop loss of $0.85 and looking at a profit to risk ratio of about 10:1. Get it. Go long
NovaBay Pharmaceuticals, Inc. engages in development of products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.